Cancer.Net Specialty Editor: Gastrointestinal Cancers
Knight Cancer institute and SWOG, Portland, OR
Dr. Charles Blanke re-joined the faculty of the Knight Cancer Institute in 2013, where he serves as a Professor of Medicine. His chief areas of clinical research are in drug and biologic targeted agent development in the treatment of gastrointestinal stromal tumors.
Dr. Blanke also serves as the Chair for SWOG, and he is currently the chair of the U.S. National Cancer Institute (NCI)-designated GIST Task Force, which coordinates gastrointestinal stromal tumor translational research across all North American cooperative groups.
Dr. Blanke received an M.D. with distinction from Northwestern University. He completed residency training at the Gundersen Medical Foundation, also serving as Chief Resident. He was a Hematology/Medical Oncology fellow at Indiana University, where he also served as Chief Fellow. He has been on faculty at Vanderbilt University and the Oregon Health and Sciences University.
Dr. Blanke is a Fellow of the American Society of Clinical Oncology (ASCO) and the American College of Physicians. He has served as a member of the writing panel for the Subspecialty Board on Medical Oncology for the American Board of Internal Medicine. He has been active in ASCO, and in addition to his role in Cancer.Net, has chaired the co-sponsored GI Cancers Symposium and served as Education Chair in 2011. He is the author or co-author of more than 80 peer-reviewed manuscripts and 140 abstracts. He is Chief Editor for a GI Oncology text recently published and he co-authored the Cecil Textbook of Medicine chapter on small and large bowel neoplasms for the last two editions. Dr. Blanke is considered one of the most prominent oncologists nationally and internationally for gastrointestinal cancers, and has been named multiple times in regional peer-selected listings of top physicians.
Last updated: September 17, 2014